Novaliq
Pre-clinicalNovaliq is a pharmaceutical company focusing on the development and commercialization of first- and best-in-class ocular therapeutics based on EyeSol®, the first and only water-free technology worldwide for ophthalmology products.
Founded
2013
Focus
Drug Delivery
About
Novaliq is a pharmaceutical company focusing on the development and commercialization of first- and best-in-class ocular therapeutics based on EyeSol®, the first and only water-free technology worldwide for ophthalmology products.
Funding History
3Total raised: $120M
Series C$60MDievini Hopp BioTech HoldingJun 15, 2020
Series B$45MDievini Hopp BioTech HoldingJun 15, 2017
Series A$15MDievini Hopp BioTech HoldingJun 15, 2012
Company Info
TypePrivate
Founded2013
LocationHeidelberg, Germany
StagePre-clinical
Contact
SIMILAR COMPANIES
300Microns
Pre-clinical · Munich
BetaSense
Pre-clinical · Berlin
AB Diagnostic Systems
Pre-clinical · Jena
bbi-biotech
Pre-clinical · Berlin
Mireca Medicines
Pre-clinical · Munich
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile